RPN2 gene confers docetaxel resistance in breast cancer (Q28509174)

24 January 2017

title

RPN2 gene confers docetaxel resistance in breast cancer (English)

1 reference

24 January 2017

1 reference

GOA release 2020-03-11

1 reference

1 reference

9

Takahiro Ochiya

1 reference

24 January 2017

Kimi Honma

1

1 reference

24 January 2017

Kyoko Iwao-Koizumi

2

1 reference

24 January 2017

Fumitaka Takeshita

3

1 reference

24 January 2017

Yusuke Yamamoto

4

1 reference

24 January 2017

Teruhiko Yoshida

5

1 reference

24 January 2017

Kazuto Nishio

6

1 reference

24 January 2017

Shunji Nagahara

7

1 reference

24 January 2017

Kikuya Kato

8

1 reference

24 January 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

24 January 2017

1 reference

24 January 2017

volume

14

1 reference

24 January 2017

issue

9

1 reference

24 January 2017

page(s)

939–948

1 reference

Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype

24 January 2017

cites work

1 reference

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

21 January 2018

1 reference

7 January 2021

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

1 reference

7 January 2021

Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial

1 reference

7 January 2021

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

1 reference

7 January 2021

Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience

1 reference

7 January 2021

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

1 reference

7 January 2021

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

1 reference

7 January 2021

P-glycoprotein and multidrug resistance

1 reference

7 January 2021

Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.

1 reference

7 January 2021

The (patho)physiological functions of the MRP family

1 reference

7 January 2021

ATP binding cassette transporters and drug resistance in breast cancer

1 reference

7 January 2021

The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia.

1 reference

7 January 2021

Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling

1 reference

7 January 2021

Prediction of docetaxel response in human breast cancer by gene expression profiling.

1 reference

7 January 2021

High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer

1 reference

7 January 2021

Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression

1 reference

7 January 2021

Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions

1 reference

7 January 2021

The role of atelocollagen-based cell transfection array in high-throughput screening of gene functions and in drug discovery

1 reference

7 January 2021

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo

1 reference

7 January 2021

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

1 reference

7 January 2021

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

1 reference

7 January 2021

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines

1 reference

7 January 2021

Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein

1 reference

7 January 2021

An evolving view of the eukaryotic oligosaccharyltransferase

1 reference

7 January 2021

The dileucine motif at the COOH terminus of human multidrug resistance P-glycoprotein is important for folding but not activity

1 reference

7 January 2021

Atelocollagen-mediated drug discovery technology

1 reference

7 January 2021

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

1 reference

7 January 2021

The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation

1 reference

7 January 2021

Regulation of the stability of P-glycoprotein by ubiquitination

1 reference

7 January 2021

Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancer--an evolving story

1 reference

7 January 2021

Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation

1 reference

7 January 2021

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

1 reference

7 January 2021

P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells

1 reference

7 January 2021

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

1 reference

7 January 2021

Apoptosis induced by topoisomerase inhibitors

1 reference

7 January 2021

Apoptosis-based therapies

1 reference

7 January 2021

BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells

1 reference

7 January 2021

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

7 January 2021

Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.

1 reference

7 January 2021

The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression

1 reference

7 January 2021

Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells

1 reference

7 January 2021

Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method

1 reference

7 January 2021